Briggiler AM - Search Results

1

Vaccine-elicited receptor-binding site antibodies neutralize two New World hemorrhagic fever arenaviruses.

Clark LE, Mahmutovic S, Raymond DD, Dilanyan T, Koma T, Manning JT, Shankar S, Levis SC, Briggiler AM, Enria DA, Wucherpfennig KW, Paessler S, Abraham J. Clark LE, et al. Among authors: briggiler am. Nat Commun. 2018 May 14;9(1):1884. doi: 10.1038/s41467-018-04271-z. Nat Commun. 2018. PMID: 29760382 Free PMC article.

2

Treatment of Argentine hemorrhagic fever.

Enria DA, Briggiler AM, Sánchez Z. Enria DA, et al. Among authors: briggiler am. Antiviral Res. 2008 Apr;78(1):132-9. doi: 10.1016/j.antiviral.2007.10.010. Epub 2007 Nov 20. Antiviral Res. 2008. PMID: 18054395 Free PMC article. Review.

3

Molecular Basis for Antibody-Mediated Neutralization of New World Hemorrhagic Fever Mammarenaviruses.

Mahmutovic S, Clark L, Levis SC, Briggiler AM, Enria DA, Harrison SC, Abraham J. Mahmutovic S, et al. Among authors: briggiler am. Cell Host Microbe. 2015 Dec 9;18(6):705-13. doi: 10.1016/j.chom.2015.11.005. Cell Host Microbe. 2015. PMID: 26651946 Free PMC article.

4

[New transmission scenarios of the Argentine hemorrhagic fever since the introduction of the live attenuated junin virus vaccine (Candid #1): an experience in migrant workers].

Briggiler A, Sinchi A, Coronel F, Sánchez Z, Levis S, Taylor J, Enria D. Briggiler A, et al. Rev Peru Med Exp Salud Publica. 2015 Jan-Mar;32(1):165-71. Rev Peru Med Exp Salud Publica. 2015. PMID: 26102120 Free article. Spanish.

5

[Candid#1 vaccine against Argentine hemorrhagic fever produced in Argentina. Immunogenicity and safety].

Enria DA, Ambrosio AM, Briggiler AM, Feuillade MR, Crivelli E; Study Group on Argentine Hemorrhagic Fever Vaccine. Enria DA, et al. Among authors: briggiler am. Medicina (B Aires). 2010;70(3):215-22. Medicina (B Aires). 2010. PMID: 20529769 Clinical Trial. Spanish.

6

Protective efficacy of a live attenuated vaccine against Argentine hemorrhagic fever. AHF Study Group.

Maiztegui JI, McKee KT Jr, Barrera Oro JG, Harrison LH, Gibbs PH, Feuillade MR, Enria DA, Briggiler AM, Levis SC, Ambrosio AM, Halsey NA, Peters CJ. Maiztegui JI, et al. Among authors: briggiler am. J Infect Dis. 1998 Feb;177(2):277-83. doi: 10.1086/514211. J Infect Dis. 1998. PMID: 9466512 Clinical Trial.

7

[Prevalence of hepatitis C antibodies in plasma donors for the treatment of Argentine hemorrhagic fever].

Saavedra MC, Briggiler AM, Enría D, Riera L, Ambrosio AM. Saavedra MC, et al. Among authors: briggiler am. Medicina (B Aires). 1997;57(3):287-93. Medicina (B Aires). 1997. PMID: 9640761 Spanish.

8

Clinical manifestations of New World hantaviruses.

Enria DA, Briggiler AM, Pini N, Levis S. Enria DA, et al. Among authors: briggiler am. Curr Top Microbiol Immunol. 2001;256:117-34. doi: 10.1007/978-3-642-56753-7_7. Curr Top Microbiol Immunol. 2001. PMID: 11217400 Review. No abstract available.

9

Assessing cross-reactivity of Junín virus-directed neutralizing antibodies.

Leske A, Waßmann I, Schnepel K, Shifflett K, Holzerland J, Bostedt L, Bohn P, Mettenleiter TC, Briggiler AM, Brignone J, Enria D, Cordo SM, Hoenen T, Groseth A. Leske A, et al. Among authors: briggiler am. Antiviral Res. 2019 Mar;163:106-116. doi: 10.1016/j.antiviral.2019.01.006. Epub 2019 Jan 19. Antiviral Res. 2019. PMID: 30668977

10

Importance of dose of neutralising antibodies in treatment of Argentine haemorrhagic fever with immune plasma.

Enria DA, Briggiler AM, Fernandez NJ, Levis SC, Maiztegui JI. Enria DA, et al. Among authors: briggiler am. Lancet. 1984 Aug 4;2(8397):255-6. doi: 10.1016/s0140-6736(84)90299-x. Lancet. 1984. PMID: 6146809

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

16 results

Search Page

Filters